146 related articles for article (PubMed ID: 16165012)
1. Chemokines in myocardial ischemia.
Frangogiannis NG; Entman ML
Trends Cardiovasc Med; 2005 Jul; 15(5):163-9. PubMed ID: 16165012
[TBL] [Abstract][Full Text] [Related]
2. CCL2/Monocyte Chemoattractant Protein-1 regulates inflammatory responses critical to healing myocardial infarcts.
Dewald O; Zymek P; Winkelmann K; Koerting A; Ren G; Abou-Khamis T; Michael LH; Rollins BJ; Entman ML; Frangogiannis NG
Circ Res; 2005 Apr; 96(8):881-9. PubMed ID: 15774854
[TBL] [Abstract][Full Text] [Related]
3. The role of the chemokines in myocardial ischemia and reperfusion.
Frangogiannis NG
Curr Vasc Pharmacol; 2004 Apr; 2(2):163-74. PubMed ID: 15320517
[TBL] [Abstract][Full Text] [Related]
4. Critical role of monocyte chemoattractant protein-1/CC chemokine ligand 2 in the pathogenesis of ischemic cardiomyopathy.
Frangogiannis NG; Dewald O; Xia Y; Ren G; Haudek S; Leucker T; Kraemer D; Taffet G; Rollins BJ; Entman ML
Circulation; 2007 Feb; 115(5):584-92. PubMed ID: 17283277
[TBL] [Abstract][Full Text] [Related]
5. Chemokines in the ischemic myocardium: from inflammation to fibrosis.
Frangogiannis NG
Inflamm Res; 2004 Nov; 53(11):585-95. PubMed ID: 15693606
[TBL] [Abstract][Full Text] [Related]
6. Critical role of endogenous thrombospondin-1 in preventing expansion of healing myocardial infarcts.
Frangogiannis NG; Ren G; Dewald O; Zymek P; Haudek S; Koerting A; Winkelmann K; Michael LH; Lawler J; Entman ML
Circulation; 2005 Jun; 111(22):2935-42. PubMed ID: 15927970
[TBL] [Abstract][Full Text] [Related]
7. Chemokines in ischemia and reperfusion.
Frangogiannis NG
Thromb Haemost; 2007 May; 97(5):738-47. PubMed ID: 17479184
[TBL] [Abstract][Full Text] [Related]
8. Chemokine and inflammatory cytokine changes during chronic wound healing.
Fivenson DP; Faria DT; Nickoloff BJ; Poverini PJ; Kunkel S; Burdick M; Strieter RM
Wound Repair Regen; 1997; 5(4):310-22. PubMed ID: 16984441
[TBL] [Abstract][Full Text] [Related]
9. DITPA, a thyroid hormone analog, reduces infarct size and attenuates the inflammatory response following myocardial ischemia.
Abohashem-Aly AA; Meng X; Li J; Sadaria MR; Ao L; Wennergren J; Fullerton DA; Raeburn CD
J Surg Res; 2011 Dec; 171(2):379-85. PubMed ID: 21658725
[TBL] [Abstract][Full Text] [Related]
10. Critical role for monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha in induction of experimental autoimmune myocarditis and effective anti-monocyte chemoattractant protein-1 gene therapy.
Göser S; Ottl R; Brodner A; Dengler TJ; Torzewski J; Egashira K; Rose NR; Katus HA; Kaya Z
Circulation; 2005 Nov; 112(22):3400-7. PubMed ID: 16316965
[TBL] [Abstract][Full Text] [Related]
11. MCP-1/CCL2 as a therapeutic target in myocardial infarction and ischemic cardiomyopathy.
Xia Y; Frangogiannis NG
Inflamm Allergy Drug Targets; 2007 Jun; 6(2):101-7. PubMed ID: 17692033
[TBL] [Abstract][Full Text] [Related]
12. Cardiac overexpression of monocyte chemoattractant protein-1 in transgenic mice prevents cardiac dysfunction and remodeling after myocardial infarction.
Morimoto H; Takahashi M; Izawa A; Ise H; Hongo M; Kolattukudy PE; Ikeda U
Circ Res; 2006 Oct; 99(8):891-9. PubMed ID: 16990567
[TBL] [Abstract][Full Text] [Related]
13. Antagonist of interferon-inducible protein 10/CXCL10 ameliorates the progression of autoimmune sialadenitis in MRL/lpr mice.
Hasegawa H; Inoue A; Kohno M; Muraoka M; Miyazaki T; Terada M; Nakayama T; Yoshie O; Nose M; Yasukawa M
Arthritis Rheum; 2006 Apr; 54(4):1174-83. PubMed ID: 16575871
[TBL] [Abstract][Full Text] [Related]
14. Compartment-specific expression and function of the chemokine IP-10/CXCL10 in a model of renal endothelial microvascular injury.
Panzer U; Steinmetz OM; Reinking RR; Meyer TN; Fehr S; Schneider A; Zahner G; Wolf G; Helmchen U; Schaerli P; Stahl RA; Thaiss F
J Am Soc Nephrol; 2006 Feb; 17(2):454-64. PubMed ID: 16382019
[TBL] [Abstract][Full Text] [Related]
15. Mast cell tryptase may modulate endothelial cell phenotype in healing myocardial infarcts.
Somasundaram P; Ren G; Nagar H; Kraemer D; Mendoza L; Michael LH; Caughey GH; Entman ML; Frangogiannis NG
J Pathol; 2005 Jan; 205(1):102-11. PubMed ID: 15586361
[TBL] [Abstract][Full Text] [Related]
16. Chemokine expression by astrocytes plays a role in microglia/macrophage activation and subsequent neurodegeneration in secondary progressive multiple sclerosis.
Tanuma N; Sakuma H; Sasaki A; Matsumoto Y
Acta Neuropathol; 2006 Aug; 112(2):195-204. PubMed ID: 16733654
[TBL] [Abstract][Full Text] [Related]
17. Targeting the chemokines in cardiac repair.
Cavalera M; Frangogiannis NG
Curr Pharm Des; 2014; 20(12):1971-9. PubMed ID: 23844733
[TBL] [Abstract][Full Text] [Related]
18. CXCR2 blockade impairs angiotensin II-induced CC chemokine synthesis and mononuclear leukocyte infiltration.
Abu Nabah YN; Losada M; Estellés R; Mateo T; Company C; Piqueras L; Lopez-Gines C; Sarau H; Cortijo J; Morcillo EJ; Jose PJ; Sanz MJ
Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2370-6. PubMed ID: 17717298
[TBL] [Abstract][Full Text] [Related]
19. Extracellular matrix remodeling in canine and mouse myocardial infarcts.
Dobaczewski M; Bujak M; Zymek P; Ren G; Entman ML; Frangogiannis NG
Cell Tissue Res; 2006 Jun; 324(3):475-88. PubMed ID: 16496177
[TBL] [Abstract][Full Text] [Related]
20. Molecular aspects of rheumatoid arthritis: chemokines in the joints of patients.
Iwamoto T; Okamoto H; Toyama Y; Momohara S
FEBS J; 2008 Sep; 275(18):4448-55. PubMed ID: 18662305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
